www.investorcalendar.com/IC/CEPage.asp?ID=175578 or www.imprimisrx.com/

Replay Information

The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on April 21, 2017.

Toll Free: 877-481-4010 International: 919-882-2331 Replay ID#: 10212 Webcast: www.investorcalendar.com or www.imprimisrx.com/

About Imprimis Pharmaceuticals

Imprimis Pharmaceuticals, Inc. (IMMY) is a pharmaceutical company dedicated to producing and dispensing high quality innovative medications in all 50 states. The company's unique business model increases patient access and affordability to many critical medicines. Headquartered in San Diego, California, Imprimis owns and operates three production and dispensing facilities located in California, New Jersey, and Pennsylvania. For more information about Imprimis, please visit the corporate website at www.ImprimisRx.com.

SOURCE: Investor Network

ReleaseID: 457736

"/> Investor Network Invites You to the Imprimis Pharmaceuticals Fourth Quarter and Year End 2016 Earnings Conference Call and Webcast Live on Tuesday, March 21, 2017 « MarketersMedia – Press Release Distribution Services – News Release Distribution Services

Investor Network Invites You to the Imprimis Pharmaceuticals Fourth Quarter and Year End 2016 Earnings Conference Call and Webcast Live on Tuesday, March 21, 2017

SAN DIEGO, CA / ACCESSWIRE / March 20, 2017 / Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) will host a conference call and live webcast to discuss the results of the fourth quarter and year end 2016, to be held Tuesday, March 21, 2017 at 4:30 PM Eastern Time.

Live Event Information

To participate, connect approximately 5 to 10 minutes before the beginning of the event.

Date, Time: March 21, 2017 at 4:30 PM ET
Toll Free: 877-407-8035
International: 201-689-8035
Live Webcast: www.investorcalendar.com/IC/CEPage.asp?ID=175578 or www.imprimisrx.com/

Replay Information

The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on April 21, 2017.

Toll Free: 877-481-4010
International: 919-882-2331
Replay ID#: 10212
Webcast: www.investorcalendar.com or www.imprimisrx.com/

About Imprimis Pharmaceuticals

Imprimis Pharmaceuticals, Inc. (IMMY) is a pharmaceutical company dedicated to producing and dispensing high quality innovative medications in all 50 states. The company's unique business model increases patient access and affordability to many critical medicines. Headquartered in San Diego, California, Imprimis owns and operates three production and dispensing facilities located in California, New Jersey, and Pennsylvania. For more information about Imprimis, please visit the corporate website at www.ImprimisRx.com.

SOURCE: Investor Network

ReleaseID: 457736

SAN DIEGO, CA / ACCESSWIRE / March 20, 2017 / Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) will host a conference call and live webcast to discuss the results of the fourth quarter and year end 2016, to be held Tuesday, March 21, 2017 at 4:30 PM Eastern Time.

Live Event Information

To participate, connect approximately 5 to 10 minutes before the beginning of the event.

Date, Time: March 21, 2017 at 4:30 PM ET
Toll Free: 877-407-8035
International: 201-689-8035
Live Webcast: www.investorcalendar.com/IC/CEPage.asp?ID=175578 or www.imprimisrx.com/

Replay Information

The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on April 21, 2017.

Toll Free: 877-481-4010
International: 919-882-2331
Replay ID#: 10212
Webcast: www.investorcalendar.com or www.imprimisrx.com/

About Imprimis Pharmaceuticals

Imprimis Pharmaceuticals, Inc. (IMMY) is a pharmaceutical company dedicated to producing and dispensing high quality innovative medications in all 50 states. The company's unique business model increases patient access and affordability to many critical medicines. Headquartered in San Diego, California, Imprimis owns and operates three production and dispensing facilities located in California, New Jersey, and Pennsylvania. For more information about Imprimis, please visit the corporate website at www.ImprimisRx.com.

SOURCE: Investor Network

ReleaseID: 457736

Source URL: https://marketersmedia.com/investor-network-invites-you-to-the-imprimis-pharmaceuticals-fourth-quarter-and-year-end-2016-earnings-conference-call-and-webcast-live-on-tuesday-march-21-2017/179516

Source: AccessWire

Release ID: 179516


Latest News